Long-term disease-free survival in three ovarian cancer patients with a single relapse

European Journal of Gynaecological Oncology

Volumn 33, Issue 3, 2012, Pages 321-323

  Chen, C Y ^a   Chang, H P ^a   Ng, K K ^a   Wang, C C ^a   Lai, C H ^a   Chao, A ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Disease free survival; Ovarian neoplasm; Recurrence; Treatment outcome

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; MITOMYCIN; PACLITAXEL; TOPOTECAN;

ABDOMINAL WALL HERNIA; ADULT; APPENDECTOMY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; CHEMORADIOTHERAPY; CHRONIC COUGH; CLEAR CELL CARCINOMA; COLON TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; INTENSITY MODULATED RADIATION THERAPY; LESSER PELVIS; LUNG METASTASIS; LUNG TUMOR; LYMPH NODE METASTASIS; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEEDLE BIOPSY; OVARY CARCINOMA; PARAAORTIC LYMPH NODE; PATHOPHYSIOLOGY; PELVIS TUMOR; POSITRON EMISSION TOMOGRAPHY; SALPINGOOOPHORECTOMY;

ADENOCARCINOMA, CLEAR CELL; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, ENDOMETRIOID; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; RADIOTHERAPY; SALPINGECTOMY; TIME FACTORS;

EID: 84863611677     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Parkin D.M., Bray F., Ferlay J., Pisani P.: "Global Cancer Statistics, 2002." CA Cancer J. Clin., 2005, 55, 74.
2. Cancer Registry Annual Report, 2008 Taiwan: Department of Health, Executive Yuan, 2010.
3. Cannistra S.A.: "Cancer of the ovary." N. Engl. J. Med., 2004, 351, 2519.
4. Armstrong D.K.: "Relapsed ovarian cancer: challenges and management strategies for a chronic disease". Oncologist, 2002, 7 (suppl. 5), 20.
5. Parmar M., Ledermann J., Colombo N., Bois Ad, Delaloye J., Kristensen G. et al: "Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial". Lancet, 2003, 361, 2099.
6. Sher-Ahmed A., Buscema J., Sardi A.: "A case report of recurrent epithelial ovarian cancer metastatic to the sternum, diaphragm, costae, and bowel managed by aggressive secondary cytoreductive surgery without postoperative chemotherapy". Gynecol. Oncol., 2002, 86, 91.
7. Micha J.P., Goldstein B.H., Hunter J.V., Rettenmaier M.A., Brown J.V.: "Long-term survival in an ovarian cancer patient with brain metastases". Gynecol. Oncol., 2004, 92, 978.
8. Chi D.S., McCaughty K., Diaz J.P, Huh J., Schwabenbauer S., Hummer A.J. et al.: "Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma". Cancer, 2006, 106, 1933.
9. Sebastian S., Lee S.I., Horowitz N.S., Scott J.A., Fischman A.J., Simeone J.F. et al: "PET-CT vs CT alone in ovarian cancer recurrence". Abdom. Imaging, 2008, 33, 112.
10. Fulham M.J., Carter J., Baldey A., Hicks R.J., Ramshaw J.E., Gibson M.: "The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project". Gynecol. Oncol., 2009, 112, 462.
11. Albuquerquea K.V., Singlaa R., Potkulb R.K., Smithb D.M., Creecha S., Loa S. et al: "Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer". Gynecol. Oncol., 2005, 96, 701.